Who doesn't like it when 'breakthrough' and 'Zantrene' are used in the same sentence?
"This research has found that Zantrene is able to protect heart muscle cells fromanthracycline (specifically doxorubicin) induced cell death while improving the killingof breast cancer cells."
Also dropped some hints in this announcement:
RAC has been a sleeping giant for the last 6 months. This will be a new catalyst for the next leg upwards and re-rate in 2022. Cannot be anymore exciting than this news and happy to be a RAC SH
GLTAH and DYOR
Ann: Breakthrough Zantrene Heart Protection Discovery, page-3
-
- There are more pages in this discussion • 364 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.65 |
Change
-0.040(2.37%) |
Mkt cap ! $281.2M | |||
| Open | High | Low | Value | Volume |
| $1.69 | $1.69 | $1.64 | $50.53K | 30.36K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 539 | $1.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.69 | 731 | 1 |
View Market Depth
| Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |